| Date | Title | Description |
| 11.03.2024 | Human Liver Model Global Market Report 2024: Surge in Clinical Trials & Innovative Model Systems to Propel Growth | - |
| 16.08.2022 | Accelerating Toward A Safer Future With Organ-Chips | Jim Corbett is CEO of Emulate. His diverse global experience ranges from Fortune 100 companies to entrepreneurial start-ups. |
| 26.05.2022 | CAARE Joins Inaugural ‘World Day of Animal Free Research’ on May 27; Notes U.S. Legislation to Remove FDA’s Animal Testing Mandate | “Cutting-edge technology has forged new frontiers in biology and medicine that have produced human-relevant models that can replace animals. It is time for federal funding and regulation to keep pace with scientific innovation by investing ... |
| 15.02.2022 | Welcome back to the FDA, Robert Califf. Let’s get to work on your big idea | Now, more than ever, the U.S. needs scientific leaders who value Americans’ health and safety, who want to improve research and testing, and who are passionate about innovative ideas.
With Robert Califf once again confirmed as the commissio... |
| 13.09.2021 | Digital health news, funding roundup in the prior week; September 13 | Beauty Pie raised $100 million; Homage landed $30M; DotCom Therapy picked up $13M
Cleveland Clinic: Cleveland Clinic is an Ohio-based medical center that combines clinical and hospital care with research and education. Anthem is teaming up ... |
| 10.09.2021 | StartUPDATES: New developments from healthcare startups | Emulate this week announced the close of an $82 million Series E financing round led by existing investor Northpond Ventures with additional participation from Perceptive Advisors. With this investment, Emulate has raised nearly $225 millio... |
| 08.09.2021 | Emulate picks up $82M | Emulate has raised an $82 million Series E led by Northpond Ventures, with participation from Perceptive Advisors. The Boston-based company offers an in vitro modeling system to help drug researchers replicate and study human biology and di... |
| 08.09.2021 | Coinbase takes its SEC battle to the public | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Paid Content How this advanced tech will help machines see like humans From Telus International
F... |
| 08.09.2021 | Coinbase takes its SEC battle to the public | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
Paid Content Why the marketer experience needs a digital upgrade From Optimizely
Few CEOs take th... |
| 07.09.2021 | Emulate Raises $82M in Series E Funding | Emulate, Inc., a Boston, MA-based provider of next generation in vitro models, closed an $82m Series E financing round.
The round, which brought total funding raised to date to nearly $225m, was led by existing investor Northpond Ventures w... |
| 07.09.2021 | Emulate Closes $82 Million Series E Financing to Scale Amid Rapid Growth in Organ-on-a-Chip Market | Emulate, Inc., a leading provider of next generation in vitro models, today announced the close of an $82 million Series E financing round led by existing investor Northpond Ventures with additional participation from Perceptive Advisors. W... |
| 07.09.2021 | Organ-on-a-chip maker Emulate secures $82M to expand scientific, commercial efforts | The organ-on-a-chip developer Emulate has raised $82 million to boost its offerings aimed at replicating human biology through easier-to-manage in vitro cellular models.
Used in past drug development collaborations with the likes of AstraZe... |
| 07.09.2021 | Emulate Inc. closes $82M Series E to fund expansion of ‘organ-on-a-chip’ products | Emulate Inc., a biotech company focused on developing “organ-on-a-chip” technology, closed an $82 million Series E round on Tuesday. This latest round is intended to formulate a massive investment in a “roadmap” for developing model organ s... |
| 07.09.2021 | Organ-on-a-chip maker Emulate secures $82M to expand scientific, commercial efforts
Age-Appropriate Formulation Development for Pediatric Trials-Challenges and Considerations | The organ-on-a-chip developer Emulate has raised $82 million to boost its offerings aimed at replicating human biology through easier-to-manage in vitro cellular models.
Used in past drug development collaborations with the likes of AstraZe... |
| 25.08.2021 | Emulate CEO shares the organ-chip maker’s vision to understand and predict drug response | Emulate is the leading provider of next generation in vitro biological models. Researchers use their organ-on-a-chip technology to understand and predict drug response with greater precision and detail than possible with conventional cell c... |
| 25.06.2021 | StartUPDATES: New developments from healthcare startups | HealthMine and Pulse8 recently hosted a free Mid-Year Stars Strategy webinar to help Medicare plans effectively prepare for the end of the measurement year. This webinar includes exclusive insights to shift your strategy and improve CAHPS f... |
| 21.05.2021 | StartUPDATES: New developments from healthcare startups | Emulate launched the Emulate Colon Intestine-Chip Grant Program this week. The program will help researchers begin using Organs-on-Chips technology to study intestinal diseases. The Emulate Colon Intestine-Chip is a physiologically relevant... |
| 18.05.2021 | Emulate Announces Colon Intestine-Chip Grant Program to Inspire Research into Intestinal Diseases | |
| 07.05.2021 | StartUPDATES: New developments from healthcare startups | In a collaboration effort to test whether existing drug candidates block infection from respiratory pathogens like SARS-CoV-2, researchers from the Wyss Institute at Harvard University, the University of Maryland School of Medicine, the Ica... |
| 02.04.2021 | Nearly 90 percent of drug candidates fail to reach the market. Can organ-chips help? | Human biologic drugs, including cancer-fighting antibodies, vaccines, or gene therapy targets, currently make up more than 40 percent of drug development pipelines. Biologics are designed to interact specifically with human cellular pathway... |
| 17.03.2021 | Emulate Launches Colon Intestine-Chip to Advance Research of Inflammatory Intestinal Diseases | |
| 08.01.2021 | Emulate Announces Organ-on-a-Chip Application and Services Roadmap | |
| 11.12.2020 | StartUPDATES: New developments from healthcare startups | A genomics awareness study from Outcomes4Me Inc. and Foundation Medicine Inc. reveals breast cancer patients are not offered genomic testing.
Genomic testing allows doctors to learn more about a tumor’s individual characteristics and ultima... |
| 08.12.2020 | Emulate Announces Lung-Chip Technology Used by U.S. Army to Study Effects of COVID-19 | |
| 07.03.2020 | The first SpaceX Dragon capsule is taking its final flight | Last night, SpaceX launched its first generation Dragon capsule on its twentieth — and final — resupply run to the International Space Station.
The launch marks the Dragon’s last mission as the capsule makes way for SpaceX’s updated and imp... |
| 21.06.2018 | Term Sheet — Thursday, June 21 | GLOBAL DOMINATION
Good morning, Term Sheet readers.
Paid Content You can't secure what you can't see From ExtraHop
Chain previously raised more than $43 million in venture funding from investors including Khosla Ventures, RRE Ventures, Bloc... |
| 19.06.2018 | Organ-chip developer Emulate raises $36M in VC funding | Organ-on-a-chip developer Emulate has gathered $36 million in series C financing, and plans to expand its platform to include a wider range of disease models for drug efficacy testing.
The Boston-based company also hopes to use the proceeds... |
| 19.06.2018 | Emulate Secures $36M in Series C Financing | Emulate, Inc., a Boston, MA-based company that creates living products for understanding how diseases, medicines, chemicals, and foods affect human health, secured a $36m Series C financing.
The round was led by Founders Fund, with particip... |
| 19.06.2018 | Organ-chip developer Emulate raises $36M in VC funding
W h i t e p a p e r
Vital Precision for Cost Reduction, QA, and Regulatory Compliance | Organ-on-a-chip developer Emulate has gathered $36 million in series C financing, and plans to expand its platform to include a wider range of disease models for drug efficacy testing.
Sponsored by Agilent Technologies
How would you like to... |
| 19.06.2018 | Founders Fund Leads $36 Million Financing Round in Emulate | Emulate, Inc. today announced that it has secured a $36 million Series C financing round led by Founders Fund. The funding also includes additional new investors including ALS Investment Fund, SciFi VC, members of GlassWall Syndicate Associ... |
| 28.10.2016 | Emulate brings engineers into the cell culture system | The company’s lead product, currently in development, is the “human emulation system,” built around customizable microfluidics chips, an instrument reader, and software that manages both.
Emulate has a lot of scientific potential, many nota... |
| 20.10.2016 | Emulate Raises $17M in Series B Round Totalling $45M | Emulate, a Boston, MA-based developer of Organs-on-Chips technology platform, expanded its Series B financing raising an additional $17m.
This brought the total amount raised in the round to $45m.
Backers includes new private individuals, i... |
| 26.07.2016 | From orthopedics to MS, Ananda Devices wants to harness the potential of organ-on-a-chip | Magdesian’s innovation is one of the latest in the organ-on-a-chip movement, which has the potential to dramatically accelerate the drug industry research and development. Scientists generally “put some cells on a Petri dish and hope they w... |
| 28.03.2016 | Organ-on-a-chip startup Emulate raises $28.75M Series B | Emulate says its organ chips mimic the functionality of specific organs — containing tiny channels that are lined with thousands of human cells and tissues. Each chip is about the size of a AA battery. This “micro-engineered environment rec... |
| 28.03.2016 | Daily funding roundup - March 28, 2016 | Emulate secured $28M; Goldman Sachs invested in Venus Medtech; Fixt received $600k Seed funding
Flyr, a San Francisco, CA-based travel and data science company, received an investment from JetBlue Technology Ventures, the new venture capita... |
| 28.03.2016 | Emulate Secures $28 Million Series B |
CAMBRIDGE, MA, Emulate, Inc. today announced that it has secured $28 million of its Series B financing.
>> Click here for more funding data on Emulate
>> To export Emulate funding data to PDF and Excel, click here
Emulate... |
| 28.03.2016 | Emulate Raises $28M in Series B Financing | Emulate, Inc., a Cambridge, MA-based maker of living products for understanding how diseases, medicines, chemicals, and foods affect human health, raised $28m in Series B financing.
Backers included existing investors Hansjörg Wyss, NanoDim... |
| 27.03.2016 | Harvard spinout Emulate scores $28M, revs up marketing for organs-on-chip tech | Emulate CSO Geraldine Hamilton
The investors behind Emulate say now's the time to move their organs-on-a-chip tech to the proverbial next level, offering a $28 million B round fashioned to fuel a marketing drive and more than double the siz... |
| 09.10.2014 | The backstory behind organs-on-chips | By Tom Ulrich
With the launch this summer of Emulate Inc., organs-on-chips – a disease-modeling platform we’ve covered several times on Vector – made the jump from academic to commercial development.
Though developed at the Wyss Institute f... |
| 28.07.2014 | Emulate Raises $12M in Series A Financing | Emulate, Inc., a Cambridge, MA-based developer of a range of applications in drug development, personalized medicine, agriculture and chemical-based consumer products, raised $12m in Series A financing.
The round was led by NanoDimension, w... |
| 28.07.2014 | Emulate Launches with $12M in Series A |
CAMBRIDGE, MA, Emulate today announced the company's launch with a $12 million Series A financing.
>> Click here for more funding data on Emulate
>> To export Emulate funding data to PDF and Excel, click here
Emulate, Inc... |
| - | StartUPDATES: New developments from healthcare startups | A genomics awareness study from Outcomes4Me Inc. and Foundation Medicine Inc. reveals breast cancer patients are not offered genomic testing.
Genomic testing allows doctors to learn more about a tumor’s individual characteristics and ultima... |
| - | Emulate brings engineers into the cell culture system | The human guinea pig may soon be extinct. He (it’s usually a ‘he’) has become endangered through the advances of cell culture science, which increasingly close the gap between in vitro testing (the classic petri dish kind) and experimental ... |
| - | StartUPDATES: New developments from healthcare startups | Emulate this week announced the close of an $82 million Series E financing round led by existing investor Northpond Ventures with additional participation from Perceptive Advisors. With this investment, Emulate has raised nearly $225 millio... |
| - | Organ-on-a-chip startup Emulate raises $28.75M Series B | Cambridge organ-on-a-chip startup Emulate has raised $28.75 million in a Series B round, with aims to commercialize its “Human Emulation System” on the R&D circuit. The idea, as with most lab-on-a-chip technologies, is to enhance in vit... |
| - | StartUPDATES: New developments from healthcare startups | Emulate launched the Emulate Colon Intestine-Chip Grant Program this week. The program will help researchers begin using Organs-on-Chips technology to study intestinal diseases. The Emulate Colon Intestine-Chip is a physiologically relevant... |
| - | Emulate CEO shares the organ-chip maker’s vision to understand and predict drug response | Emulate is the leading provider of next generation in vitro biological models. Researchers use their organ-on-a-chip technology to understand and predict drug response with greater precision and detail than possible with conventional cell c... |
| - | From orthopedics to MS, Ananda Devices wants to harness the potential of organ-on-a-chip | Regrowing neurons: Organ-on-a-chip (left) vs. Petri dish. Source: Ananda Devices
McGill University Biochemist Margaret Magdesian, the CEO and founder of Ananda Devices, was tired of seeing her cells die prematurely in a Petri dish, so she c... |
| - | StartUPDATES: New developments from healthcare startups | HealthMine and Pulse8 recently hosted a free Mid-Year Stars Strategy webinar to help Medicare plans effectively prepare for the end of the measurement year. This webinar includes exclusive insights to shift your strategy and improve CAHPS f... |
| - | StartUPDATES: New developments from healthcare startups | In a collaboration effort to test whether existing drug candidates block infection from respiratory pathogens like SARS-CoV-2, researchers from the Wyss Institute at Harvard University, the University of Maryland School of Medicine, the Ica... |
